💊 #FDA Drug Approvals — September 2026
#Lirafugratinib, #Isembyld & #Zanvastro bring new approaches targeting FGFR, myostatin & RNA.

#Sevabertinib, #Camizestrant, #Imlunestrant, #Aqneursa & #Joenja expand therapeutic options across cancer, rare diseases & genetic disorders.

Today's Weekly View includes ICER President and CEO Sarah Emond's perspective on the apitegromab approval (now branded Isembyld). Read here: conta.cc/4y2W6dF

#isembyld #DrugPricing #PharmaPricing #ValueBasedPricing #MarketAccess #Healthcare

The #FDA has approved #Isembyld (#apitegromab-mstn) for adults and children ≥2 years with spinal muscular atrophy (#SMA) who are receiving an SMN2-targeted treatment.
🔬MedChemExpress offers apitegromab for research use only: https://www.medchemexpress.com/apitegromab.html

FDA Grants Approval for ISEMBYLD™, a New Hope for SMA Patients #United_States #Schaumburg #Cure_SMA #SMA_Treatment #ISEMBYLD™